200 related articles for article (PubMed ID: 18837814)
1. Percutaneous transluminal septal myocardial ablation in a child with hypertrophic obstructive cardiomyopathy and Noonan syndrome.
Singh H; Kalra R; Keshavamurthy GB; Singh M; Singh C
Congenit Heart Dis; 2008; 3(5):347-51. PubMed ID: 18837814
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
Seggewiss H; Faber L
Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
[TBL] [Abstract][Full Text] [Related]
3. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
Seggewiss H; Faber L; Ziemssen P; Gleichmann U
Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
[TBL] [Abstract][Full Text] [Related]
4. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD
J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
[TBL] [Abstract][Full Text] [Related]
5. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
[TBL] [Abstract][Full Text] [Related]
6. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
[TBL] [Abstract][Full Text] [Related]
7. [Percutaneous transluminal septal myocardial ablation in the treatment of hypertrophic obstructive cardiomyopathy: short-term study].
Veselka J; Tesar D; Urbanová T; Telekes P; Honĕk T; Neuwirth J
Vnitr Lek; 2001 Jul; 47(7):437-43. PubMed ID: 11505713
[TBL] [Abstract][Full Text] [Related]
8. Midterm outcomes of percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
Chen SL; Ye F; Xu ZL; Lin S; Duan BX; Dai ZL; Shan SJ; Zhang JJ
Chin Med J (Engl); 2006 Jul; 119(13):1121-4. PubMed ID: 16834933
[No Abstract] [Full Text] [Related]
9. Long-term electrocardiographic findings in patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
Haghjoo M
J Electrocardiol; 2007 Oct; 40(4):357.e1-2. PubMed ID: 17599476
[No Abstract] [Full Text] [Related]
10. Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy.
Cheng TO
Am J Cardiol; 2004 Oct; 94(7):982. PubMed ID: 15464700
[No Abstract] [Full Text] [Related]
11. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Faber L
Eur J Med Res; 2006 Oct; 11(10):423-31. PubMed ID: 17107876
[TBL] [Abstract][Full Text] [Related]
12. Multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation in a Noonan syndrome patient with hypertrophic obstructive cardiomyopathy.
Maekawa Y; Jinzaki M; Tsuruta H; Yamada Y; Kishino Y; Kawakami T; Hayashida K; Yuasa S; Murata M; Kawamura A; Sano M; Kuribayashi S; Fukuda K
Int J Cardiol; 2014; 172(1):e79-81. PubMed ID: 24411913
[No Abstract] [Full Text] [Related]
13. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Zhang W; Li Z; Zhang M; Yuan L; Guan R; Hou A; Jin Y; Deng Z
Chin Med J (Engl); 2002 Sep; 115(9):1283-6. PubMed ID: 12411095
[TBL] [Abstract][Full Text] [Related]
14. "Moving left ventricular obstruction" due to stress cardiomyopathy in a patient with hypertrophic obstructive cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
Akita K; Maekawa Y; Tsuruta H; Okuda S; Yanagisawa R; Kageyama T; Kawakami T; Kanazawa H; Hayashida K; Yuasa S; Murata M; Jinzaki M; Fukuda K
Int J Cardiol; 2016 Jan; 202():194-5. PubMed ID: 26397409
[No Abstract] [Full Text] [Related]
15. [Repeated percutaneous transluminal septal myocardial ablation leads to reduction of left ventricular outflow-tract pressure gradient in hypertrophic obstructive cardiomyopathy: a case report].
Takeda M; Mori T; Ohashi Y; Ichikawa S; Terashima M; Ejiri J; Awano K
J Cardiol; 2006 Jun; 47(6):313-21. PubMed ID: 16800375
[TBL] [Abstract][Full Text] [Related]
16. Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.
Jensen MK; Havndrup O; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
Scand Cardiovasc J; 2011 Jun; 45(3):153-60. PubMed ID: 21604920
[TBL] [Abstract][Full Text] [Related]
17. [Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol].
Miric M; Sagic D; Popovic Z; Zlatanovic M; Vlahovic A; Vidakovic R; Bojic M
Srp Arh Celok Lek; 2001; 129(7-8):199-202. PubMed ID: 11797450
[TBL] [Abstract][Full Text] [Related]
18. Extended myectomy for hypertrophic obstructive cardiomyopathy after failure or contraindication of septal ablation or with combined surgical procedures.
Dörge H; Schmitto JD; Liakopoulos OJ; Walther S; Schöndube FA
Thorac Cardiovasc Surg; 2004 Dec; 52(6):344-8. PubMed ID: 15573275
[TBL] [Abstract][Full Text] [Related]
19. [Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy].
Antolinos Pérez MJ; de la Morena Valenzuela G; Gimeno Blanes JR; Cerdán Sánchez Mdel C; Hurtado Martínez JA; Valdés Chavarri M
Rev Esp Cardiol; 2005 Jul; 58(7):872-4. PubMed ID: 16022820
[TBL] [Abstract][Full Text] [Related]
20. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Kimmelstiel CD; Maron BJ
Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
[No Abstract] [Full Text] [Related]
[Next] [New Search]
